Panitumumab Biosimilar, Endotoxin 0.05 EU/mg | C012P.05
$720.00 – $1,440.00
Panitumumab Biosimilar, Endotoxin 0.05 EU/mg. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available.
- Details & Specifications
- References
- More Offers
Catalog No. | C012P.05 |
---|---|
Product Name | Panitumumab Biosimilar, Endotoxin 0.05 EU/mg | C012P.05 |
Supplier Name | Syd Labs, Inc. |
Brand Name | Syd Labs |
Synonyms | Anti-ErbB-1 Human Monoclonal Antibody, Anti-HER1 Human Monoclonal Antibody |
Summary | Recombinant Humanized IgG2 Monoclonal Antibody. |
Isotype | Human IgG2 kappa. |
Source/Host | The monoclonal antibody panitumumab biosimilar was produced in the Panitumumab biosimilar CHO stable cell line. |
Specificity/Sensitivity | The monoclonal antibody panitumumab biosimilar specifically binds to the human EGFR, ErbB-1 and HER1. |
Form Of Antibody | 0.2 uM filtered solution, pH 6.0, no stabilizers or preservatives. |
Endotoxin | < 0.05 EU per 1 mg of the protein by the LAL method. |
Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
Shipping | The Panitumumab Biosimilar, Endotoxin 0.05 EU/mg is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
Note | Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein.The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available. |
Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C012P.05: Panitumumab Biosimilar, Endotoxin 0.05 EU/mg
Recombinant Humanized IgG2 Monoclonal Antibody.
Background
Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS”.
Syd Labs also provides the following anti-ErbB/HER antibody biosimilar stable cell lines:
Cetuximab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Trastuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Pertuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Syd Labs also provides the following research grade antibody biosimilar proteins:
Bevacizumab Biosimilar, research grade (VEGF-A)
Ranibizumab Biosimilar, research grade (VEGF-A, Fab produced in E. coli)
Cetuximab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Panitumumab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Trastuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Pertuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Infliximab biosimilar, research grade (TNF alpha)
Adalimumab biosimilar, research grade (TNF alpha)
Rituximab biosimilar, research grade (CD20)
Denosumab biosimilar, research grade (RANKL, RANK ligand, OPGL, TNFSF11, CD254, TRANCE, ODF)
Palivizumab Biosimilar, research grade (RSV)
Omalizumab biosimilar, research grade (IgE)
Eculizumab biosimilar, research grade (C5)
Please remember our product information: Panitumumab Biosimilar, Endotoxin 0.05 EU/mg: C012P.05 Syd Labs